Larry J. Small Dmd Pllc Dentist Medicare: Not Enrolled in Medicare Practice Location: 2822 Highway 71, Suite H, Mariann, FL 32446 Phone: 850-272-9393 Fax: 850-372-4540 |
News Archive
Genentech, a member of the Roche Group, announced today that people with HER2-positive metastatic breast cancer (mBC) lived significantly longer (overall survival) when treated with the combination of Perjeta (pertuzumab), Herceptin (trastuzumab) and docetaxel chemotherapy, compared to Herceptin and docetaxel chemotherapy alone in the Phase III CLEOPATRA study.
A new study from the Center for Retirement Research at Boston College found that people "who enter retirement in good health are likely to pay more for medical expenses throughout the rest of their life than those who retire after developing a chronic condition," writes U.S. News & World Report.
Cancer patients who have been hospitalized for mental health problems prior to their cancer diagnosis were 73% more likely to die from their cancer compared to those who had never had psychiatric help, according to new research published in the British Journal of Cancer.
Access Pharmaceuticals, Inc., a biopharmaceutical company specializing in products for cancer and supportive care signed a $30 million supply agreement for MuGard with RHEI Pharmaceuticals, Inc., a specialty pharmaceutical company focused on bringing proprietary medicines to the China market. Access will ensure manufacturing capacity of up to a minimum of $30 million of product in the licensed territories.
The Minneapolis-St. Paul Star Tribune: The Institute for Clinical Systems Improvement will make a system that helps doctors make more informed decisions available Minnesota doctors next year. The system has apparently eliminated about $28 million a year in unnecessary tests in a trial program in which it was made available to about 2,000 Minnesota doctors.
› Verified 3 days ago